EF-031

N/A

Report date: 2024/11/21 13:51:11
NME

Base Information

Drug NameEF-031
Drug Alias NameEF-031EF031
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 modulatorsSerine/threonine-protein kinase mTOR modulators
TargetsDNA (cytosine-5)-methyltransferase 1Serine/threonine-protein kinase mTOR
Therapy Area/IndicationsPancreatic NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEverfront Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverfront Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A